EP 0863756 A1 19980916 - USE OF 2-IMINOBENZOTHIAZOLINES FOR TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
Title (en)
USE OF 2-IMINOBENZOTHIAZOLINES FOR TREATING PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES
Title (de)
VERWENDUNG VON 2-IMINOBENZOTHIAZOLINE ZUR BEHANDLUNG VON PARKINSON UND PARKINSONARTIGEN SYNDROMEN
Title (fr)
APPLICATION DE 2-IMINOBENZOTHIAZOLINES DANS LE TRAITEMENT DU PARKINSON ET DES SYNDROMES PARKINSONIENS
Publication
Application
Priority
- FR 9601867 W 19961126
- FR 9514240 A 19951201
Abstract (en)
[origin: WO9720558A1] The use of 2-iminobenzothiazolines of formula (II), wherein R is a polyfluoroalkoxy or polyfluoroalkyl radical, R1 is a hydrogen atom or a C1-4 alkyl radical, R2 is a 2-propynyl, -alk-S(O)n-alk, -alk-SO2-NH2, -alk-SO2-NHalk or 4-phenylpiperazinylethyl radical, n is 0, 1 or 2 and alk is alkyl, and enantiomers, diastereoisomers and pharmaceutically acceptable salts thereof, for treating Parkinson's disease and parkinsonian syndromes, is disclosed.
IPC 1-7
IPC 8 full level
C07D 277/82 (2006.01); A61K 31/00 (2006.01); A61K 31/425 (2006.01); A61K 31/428 (2006.01); A61P 25/16 (2006.01)
CPC (source: EP)
A61K 31/428 (2013.01); A61P 25/16 (2017.12)
Citation (search report)
See references of WO 9720558A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9720558 A1 19970612; AU 7699496 A 19970627; EP 0863756 A1 19980916; FR 2741804 A1 19970606; FR 2741804 B1 19980102; JP 2000505060 A 20000425; ZA 969968 B 19970613
DOCDB simple family (application)
FR 9601867 W 19961126; AU 7699496 A 19961126; EP 96939977 A 19961126; FR 9514240 A 19951201; JP 52102597 A 19961126; ZA 969968 A 19961127